Full Name
Mr., Claudia Gene Jiménez Weil
Job Title
General Manager
Alternative Gene Expression S.L.
Speaker Bio
Claudia has 20 years of experience and a proven record of accomplishment in corporate development, investor relations and communications. She started her career in corporate finance at WestLB AG in Germany, where she managed mergers and acquisition (M&A) projects across various industries. Following the completion of her MBA at Instituto de Empresa in 2005, she joined the biotechnology company TiGenix, taking responsibility for corporate development and leading the company’s partnering efforts that culminated in a deal with Takeda worth up to €380M. Following the company’s Nasdaq IPO, Claudia became responsible for investor relations and corporate communications until the completion of the acquisition of TiGenix by Takeda in 2018.
Claudia Jiménez Weil